All Blogs
May 10, 2022
AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA
AstraZeneca’s Farxiga Meets Primary Endpoints in Phase 3 Heart Failure Trial Farxiga, an SGLT2 inhibitor from AstraZeneca, has shown positive results in a phase 3 Heart Failure trial, putting it back in contention with Jardiance from Boehringer Ingelheim and Eli Lilly. The DELIVER trial's top-line results demons...
Read More...
May 09, 2022
Most Promising Therapies in the Food Allergy Treatment Market
Food allergies are becoming a global concern. According to the World Allergy Organization, "food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%." The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that ...
Read More...
Sep 25, 2025
Which Pharma Companies are Going to Transform the Post-Traumatic Stress Disorder Treatment Market?
Post-Traumatic Stress Disorder (PTSD) is a complex physical, cognitive, emotional, and behavioral consequence of psychological trauma. It is characterized by intrusive thoughts, nightmares, flashbacks to past traumatic events, avoidance of traumatic reminders, hypervigilance, and sleep disturbance, all of which con...
Read More...
May 05, 2022
GE and Medtronic’s Collaboration; Vivalink’s Multi-Vital Blood Pressure Patch; Foldax’s TRIA Biopolymer Surgical Aortic Heart Valve; Vektor Medical’s vMap Clinical Validation Study; iSono’s ATUS System; Mirvie’s Test to Identify Risk of Preeclampsia
GE Healthcare and Medtronic Collaborated to Meet the Increasing Need for Outpatient Care On April 28, 2022, GE Healthcare and Medtronic entered into a collaboration to provide patients, clinicians, and payers seeking more choices of excellent care, inside and outside of the traditional hospital without compromis...
Read More...
May 04, 2022
How 3D Bioprinting Technology is Revolutionizing the Healthcare Industry?
3D printing or additive manufacturing is the method of constructing a 3D object from a digital file. The technique is in use for several years and had a strong response from industries such as manufacturing, the art & jewelry industry, aerospace (or astrospace), construction, home development, soft sensors (and...
Read More...
May 03, 2022
VBL Therapeutics’ VB-111 (ofranergene obadenovec); BMS’s mavacamten (Camzyos); Merck’s KEYTRUDA; AstraZeneca and Daiichi’s Enhertu; Pfizer/Biohaven’s VYDURA (rimegepant); AstraZeneca’s Ultomiris; Supernus’s Viloxazine (Qlebree); AbbVie’s Rinvoq
FDA Grants Fast Track Designation to VB-111 for Platinium-resistant Ovarian Cancer The FDA has given VBL Therapeutics’ VB-111 (ofranergene obadenovec), a targeted anticancer viral gene therapy, fast track designation for use as a viable therapeutic option in patients with platinum-resistant Ovarian Cancer. VB...
Read More...
May 02, 2022
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase the Odds of Success?
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of the type of biopharmaceutical products innovated and launched, evolving from management of chronic diseases in the 1990s to the expansive marketing of generic drugs, to now moving onto personalized therapies. To increase the suc...
Read More...
Apr 29, 2022
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated structures and functions associated with the living human organs. The microdevices are composed of a clear flexible polymer that is almost the size of a USB memory stick and comprises hollow microfluidic channels lined up with l...
Read More...
Apr 28, 2022
MEDIT’s i700 Intraoral Scanner; Phantom Neuro and Blackrock’s Next-Generation Assistive Devices; Fresenius Medical’s Versi PD Cycler System; Franklin Mountain’s Dual Lumen Catheter for Cardiac Applications; Bioretec’s Bioresorbable Implant; Vectorious’s VECTOR-HF II Study
MEDIT Announces Launch of i700 Intraoral Scanner On April 20, 2022, based on the success of i700 intraoral scanner, MEDIT Corp launched the all new i700 wireless intraoral scanner is light, fast, accurate, and now – wire-free. i700 wireless is a lightweight, wire-free device that offers a smooth and qui...
Read More...
Apr 27, 2022
How is Artificial Intelligence Used in Drug Discovery & Development?
Artificial intelligence (AI) has become a part of modern life and continues to pique people's interests. AI enables computers and robots to learn from past behaviour and mistakes in the same way that people can. It has permeated our daily lives, from search engines to self-driving cars to Siri. AI has the ability t...
Read More...